Deutsche Bank AG set a €85.00 ($100.00) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Wednesday morning. The firm currently has a neutral rating on the stock.

Several other research analysts also recently weighed in on the company. Nord/LB set a €93.00 ($109.41) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, May 4th. J P Morgan Chase & Co set a €106.40 ($125.18) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Saturday, May 20th. S&P Global set a €88.00 ($103.53) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Wednesday, May 3rd. Morgan Stanley set a €90.00 ($105.88) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, April 27th. Finally, Berenberg Bank set a €95.00 ($111.76) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Monday, April 24th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of Hold and an average price target of €88.07 ($103.61).

Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 79.159 on Wednesday. The firm has a market capitalization of €24.29 billion and a P/E ratio of 20.412. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €70.82 and a 52 week high of €89.07. The stock’s 50 day moving average price is €84.82 and its 200 day moving average price is €81.06.

TRADEMARK VIOLATION NOTICE: This piece was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/05/deutsche-bank-ag-reiterates-85-00-price-target-for-fresenius-medical-care-ag-co-kgaa-etrfme.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.